Large Molecule Bioanalytical Testing Service Market Size, Share, Growth & Forecast 2032

Large Molecule Bioanalytical Testing Service Market Insights

According to the report published by Zion Market Research, the global Large Molecule Bioanalytical Testing Service Market size was valued at USD 1462.24 Million in 2023 and is predicted to reach USD 4214.02 Million by the end of 2032. The market is expected to grow with a CAGR of 12.48% during the forecast period. The report analyzes the global Large Molecule Bioanalytical Testing Service Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Large Molecule Bioanalytical Testing Service industry.

Request Free Sample

Global Large Molecule Bioanalytical Testing Service Market: Overview

Bioanalysis of large molecules is one of the categories of analytical chemistry which analyses large molecule therapeutics in a biological matrix. It refers to a set of procedures, methods, and assays that allows scientists to analyze the large molecules as well as biochemical reactions underlying life processes. Most of the common types of bioanalytical studies include pharmacodynamic studies, pharmacokinetic studies, biomarker assay, and immunogenicity testing. Large molecule products are developed on a large scale and thus, the need for bioanalysis is essential which is been done by clinical research organizations by offering large molecule bioanalytical testing services.

Global Large Molecule Bioanalytical Testing Service Market: Growth Factors

The rise in the use of large molecules in biopharmaceutical companies, increase in adoption of outsourcing services by biotech & pharmaceutical companies, and rise in the need for novel drugs for combating the diseases are some of the major aspects that are fueling the growth of the global large molecule bioanalytical testing service market. Monoclonal antibodies, peptides, antibody-drug conjugates, and proteins are large molecule drug products that have proved to be very effective against several disease indications. Thus, there is a rise in the development of large molecule products. In addition to this, there is a large number of service providers that offer large molecule bioanalytical testing services to pharmaceutical companies. The state-of-the-art bioanalytical laboratories feature a wide range of innovative platforms that leverages several assays including cell-based assays, pharmacokinetics, immunogenicity, and biomarkers to optimize reproducibility and accuracy.

The service providers support the progress of large molecule innovations confidently & quickly through the drug development pipeline with proven regulatory and scientific expertise. They offer integrated bioanalytical lab services right from discovery to phases I-IV and this compresses the timeline from discovery to market. All these factors are driving the growth of the market. Moreover, the growing need for biomarker identification, pharmacokinetics, immunogenicity, and toxicokinetic studies are also the factors that are spurring the growth of the global market. Furthermore, technological advancements in the medical sciences and growing research on the development of innovative drugs will provide several opportunities for the growth of the global large molecule bioanalytical testing services market over the forecast period. However, lack of expertise will hamper the growth of the global large molecule bioanalytical testing service market.

In the first half of the year 2020, the pandemic of Covid-19 affected the growth of the global large molecule bioanalytical testing service market. This is due to the decision of the government across the world to impose complete lockdown and restriction on movement to control the spread of the disease. The disruption in the supply chain and lack of workers affected the manufacturing units of the pharmaceutical industry. The drug development programs and clinical trials were halted temporarily. However, with ease in restrictions, the service providers are supporting Covid-19 clinical trials which are leading to the growth of the global market.

Request Free Sample

Global Large Molecule Bioanalytical Testing Service Market: Segmentation

The global large molecule bioanalytical testing service market is classified based on type, phase, therapeutic area, test type, end-user, and region. Based on the type, the global large molecule bioanalytical testing service market is bifurcated into ADA, pharmacokinetics, and others. Based on phase, the global market is categorized into without antibody, with antibody, clinical, and preclinical. The therapeutic area segment is divided into cardiology, oncology, neurology, infectious diseases, and others. Based on the test type, the market is split into PD, PK, ADME, bioequivalence, bioavailability, and others. The end-user segment is fragmented into large firms and SMEs.

Large Molecule Bioanalytical Testing Service Market: Report Scope

Global Large Molecule Bioanalytical Testing Service Market: Regional Analysis

The global large molecule bioanalytical testing service market is expected to be dominated by North America over the forecast period. Factors such as the presence of well-equipped bioanalytical laboratories, the presence of a large number of CROs offering large molecule bioanalytical testing services, and the rapid adoption of advanced technologies. Asia Pacific region is estimated to grow substantially due to heavy investments in the healthcare infrastructure and a rise in focus on drug discovery & development programs. Europe is also expected to account for a significant share due to the rise in the inclination of the pharmaceuticals towards outsourcing services.

Global Large Molecule Bioanalytical Testing Service Market: Competitive Players

• Pace Analytical Services LLC
• Toxikon
• Syneos Health
• Covance, Inc.
• Intertek Group plc
• SGS SA
• Charles River Laboratory International
• Iqvia
• ICON Plc
• Pace Analytical Services LLC

are some of the key participants in the global large molecule bioanalytical testing service market.

The Global Large Molecule Bioanalytical Testing Service Market is segmented as follows:

By type 

• ADA
• pharmacokinetics 
• and others

By phase 

• without antibody
• with antibody
• clinical
• preclinical 

By therapeutic area 

• cardiology
• oncology
• neurology 
• infectious diseases
• and others

By test type 

• PD 
• PK
• ADME 
• bioequivalence
• bioavailability
• and others

By end-user 

• large firms
• SMEs

Global Large Molecule Bioanalytical Testing Service Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.